Industry: Pharmaceuticals, Biotechnology
Generex is engaged in the research and development of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company’s proprietary RapidMist(TM) device. The Company’s flagship product, oral insulin (Generex Oral-lyn(TM)), which is available for sale in Ecuador for the treatment of patients with Type-1 and Type-2 diabetes, is in various stages of clinical trials around the world. Antigen Express is a wholly owned subsidiary of ( www.generex.com )
Generex Biotechnology Corporation
33 Harbour Square Suite 202
Toronto, Ontario M5J 2G2
Canada
Tel: (416) 364-2551
Fax: (416) 364-9363